---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-22-000197"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2022-12-06T23:59:59+00:00"
generated_at: "2026-06-21T08:35:04.543433+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics appoints Jeffrey S. Sherman as CFO; William Bonello steps down

## Summary
- Jeffrey S. Sherman named CFO effective Dec 7, 2022; William Bonello remains as employee for transition support.
- Base salary $525,000; annual target bonus 70% of salary; sign-on cash $250,000; sign-on equity $3,000,000 (RSUs and options).
- Sherman has 32 years healthcare finance experience, previously CFO at Privia Health, HMS, AccentCare, Lifepoint Hospitals.
- Sherman led the sale of HMS to Veritas-backed Gainwell Technologies for $3.4 billion in April 2021.
- CEO Chris Smith highlights Sherman's skills in pricing, revenue cycle management to return NeoGenomics to profitable growth.

## SEC filing metadata
- accession: 0001077183-22-000197
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2022-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000197/0001077183-22-000197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000197/neo-20221205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-22-000197
- JSON: https://secwatch.observer/filing/0001077183-22-000197.json
- Plain text: https://secwatch.observer/filing/0001077183-22-000197.txt

## Key facts
- Executive change
  Jeffrey S. Sherman was appointed as Chief Financial Officer at NEOGENOMICS INC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On December 5, 2022, the Company appointed Jeffrey S. Sherman, age 57, as Chief Financial Officer of the Company, effective December 7, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000197/0001077183-22-000197-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.